Crinetics Pharmaceuticals, Inc. (CRNX)
USD 52.09
(-5.92%)
USD 52.09
(-5.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -166.3 Million | -115.2 Million | -88.58 Million | -62.02 Million | -46.38 Million | -19.45 Million |
| Net Income | -214.52 Million | -163.91 Million | -107.64 Million | -73.81 Million | -50.42 Million | -27.11 Million |
| Depreciation & Amortization | 1.09 Million | 983 Thousand | 922 Thousand | 948 Thousand | 887 Thousand | 471 Thousand |
| Deferred income taxes | -28.48 Million | - | 422 Thousand | -227 Thousand | -1.22 Million | - |
| Stock-based compensation | 40.93 Million | 28.26 Million | 17.35 Million | 10.42 Million | 6.29 Million | 2.32 Million |
| Change in working capital | 8.04 Million | 18.61 Million | 1.09 Million | 376 Thousand | -2.13 Million | 5.29 Million |
| Other non-cash items | 26.62 Million | 850 Thousand | -739 Thousand | 261 Thousand | 222 Thousand | -433 Thousand |
| Investing Cash Flow | -200.41 Million | -173.98 Million | -56.48 Million | 217 Thousand | 41.66 Million | -119.45 Million |
| Investments in PPE | -4.68 Million | -1.65 Million | -436 Thousand | -186 Thousand | -492 Thousand | -1.05 Million |
| Acquisitions | 195.72 Million | 34 Thousand | 422 Thousand | -227 Thousand | -1.22 Million | - |
| Investment purchases | -532.85 Million | -329.81 Million | -125.4 Million | -135.59 Million | -108.13 Million | -118.39 Million |
| Sales/Maturities of investments | 337.13 Million | 157.49 Million | 69.35 Million | 135.99 Million | 150.29 Million | - |
| Other Investing Activities | -195.72 Million | -34 Thousand | -422 Thousand | 227 Thousand | 1.22 Million | -118.39 Million |
| Financing Cash Flow | 388.94 Million | 121.96 Million | 252.67 Million | 114.57 Million | 67 Thousand | 170.19 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -59 Thousand | - |
| Common Stock Issuance | 388.94 Million | 121.96 Million | 249.54 Million | 114.28 Million | 126 Thousand | 170.19 Million |
| Other Financing Activities | 388.94 Million | 121.96 Million | 3.13 Million | 288 Thousand | 67 Thousand | 170.19 Million |
| Accounts receivables | 14.64 Million | 10.99 Million | 6.29 Million | 2.72 Million | - | - |
| Accounts payables | 14.64 Million | 10.99 Million | 6.29 Million | 2.72 Million | 696 Thousand | 7.36 Million |
| Inventory | -14.64 Million | - | -6.29 Million | -2.72 Million | - | - |
| Other working capital | -6.6 Million | -3.37 Million | -5.19 Million | -2.34 Million | -2.82 Million | -2.06 Million |
| Cash at beginning of period | 32.67 Million | 201.19 Million | 93.58 Million | 40.82 Million | 45.47 Million | 14.19 Million |
| Cash at end of period | 54.89 Million | 33.97 Million | 201.19 Million | 93.58 Million | 40.82 Million | 45.47 Million |
| Capital Expenditure | -4.68 Million | -1.65 Million | -436 Thousand | -186 Thousand | -492 Thousand | -1.05 Million |
| Effect of forex changes on cash | 1001.00 | - | - | - | - | - |
| Net cash flow / Change in cash | 22.22 Million | -167.22 Million | 107.6 Million | 52.76 Million | -4.64 Million | 31.28 Million |
| Free Cash Flow | -170.99 Million | -116.86 Million | -89.02 Million | -62.21 Million | -46.87 Million | -20.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -74.05 Million | -66.93 Million | -214.52 Million | -60.09 Million | -57.45 Million | -50.97 Million |
| Depreciation & Amortization | 753 Thousand | 474 Thousand | 1.09 Million | 262 Thousand | 273 Thousand | 280 Thousand |
| Deferred income taxes | - | - | -28.48 Million | - | -7.21 Million | -905 Thousand |
| Stock-based compensation | 18.94 Million | 13.45 Million | 40.93 Million | 11.61 Million | 11.04 Million | 10.17 Million |
| Change in working capital | 11.4 Million | 2.69 Million | 8.04 Million | 8.3 Million | 4.85 Million | -4.42 Million |
| Other non-cash items | 10.55 Million | 10.55 Million | 26.62 Million | 9.35 Million | 7.15 Million | 118 Thousand |
| Investing Cash Flow | -53.64 Million | 309 Thousand | -200.41 Million | -87.3 Million | -193.29 Million | 31.43 Million |
| Investments in PPE | -955 Thousand | -1.33 Million | -4.68 Million | -935 Thousand | -3.5 Million | -237 Thousand |
| Acquisitions | - | - | 195.72 Million | - | 189.79 Million | -31.67 Million |
| Investment purchases | -191.98 Million | -99.74 Million | -532.85 Million | -173.05 Million | -277.64 Million | -59.49 Million |
| Sales/Maturities of investments | 139.3 Million | 101.38 Million | 337.13 Million | 86.67 Million | 87.84 Million | 91.16 Million |
| Other Investing Activities | -52.68 Million | 1.64 Million | -195.72 Million | -86.37 Million | -189.79 Million | 31.67 Million |
| Financing Cash Flow | 5.49 Million | 393.57 Million | 388.94 Million | 37.92 Million | 337.87 Million | 12.65 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.49 Million | 393.57 Million | 388.94 Million | 37.92 Million | 337.87 Million | 12.65 Million |
| Other Financing Activities | 5.49 Million | 393.57 Million | 388.94 Million | 37.92 Million | 337.87 Million | 12.65 Million |
| Accounts receivables | - | - | 14.64 Million | - | - | - |
| Accounts payables | 7.23 Million | 1.3 Million | 14.64 Million | 4.19 Million | 4.38 Million | 7.41 Million |
| Inventory | - | - | -14.64 Million | - | - | - |
| Other working capital | 4.16 Million | 1.38 Million | -6.6 Million | 4.11 Million | 470 Thousand | -11.84 Million |
| Cash at beginning of period | 395.92 Million | 54.89 Million | 32.67 Million | 142.79 Million | 39.55 Million | 42.49 Million |
| Cash at end of period | 302.16 Million | 395.92 Million | 54.89 Million | 54.89 Million | 142.79 Million | 40.85 Million |
| Capital Expenditure | -955 Thousand | -1.33 Million | -4.68 Million | -935 Thousand | -3.5 Million | -237 Thousand |
| Effect of forex changes on cash | - | - | 1001.00 | - | - | - |
| Net cash flow / Change in cash | -93.76 Million | 341.02 Million | 22.22 Million | -87.89 Million | 103.24 Million | -1.64 Million |
| Free Cash Flow | -46.57 Million | -54.18 Million | -170.99 Million | -39.45 Million | -44.83 Million | -45.97 Million |
CHOLAHLDNG
BASANTGL
ACR-PC
UPST
WANBURY
0QQ4